Shifts at Pfizer

Pfizer is closing a research and development site in the UK at Sandwich, Kent, notes In the Pipeline's Derek Lowe. About 2,400 people work at the site and Pfizer says that it hopes to transfer a few those positions to other sites. "Although the company says that perhaps several hundred may find positions elsewhere, this is a major blow to drug discovery operations in the UK," Lowe says.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new study finds that a placental protein linked with preeclampsia can be targeted by RNA silencing, according to the New Scientist.

A settlement is expected in a Duke University lawsuit hinging on using falsified data to win grants, Retraction Watch and Science report.

In PNAS this week: approach for analyzing the expression of endogenous retroviruses, circular RNAs that influence host-virus interactions, and more.

A phylogenetic analysis finds that the rare hemimastigotes form their own supra-kingdom, CBC reports.